These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 169487)

  • 1. On the role of alpha-methyldopamine in the antihypertensive effect of alpha-methyldopa.
    Waldmeier P; Hedwal PR; Maître L
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 289(3):303-14. PubMed ID: 169487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood pressure and noradrenaline levels after treatment with alpha-methyldopa, alpha-methyldopamine and alpha-methyl-m-tyrosine.
    Henning M
    J Pharm Pharmacol; 1967 Nov; 19(11):775-9. PubMed ID: 4383705
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute and chronic administration of alpha-methyldopa: regional levels of endogenous and alpha-methylated catecholamines in rat brain.
    Conway EL; Louis WJ; Jarrott B
    Eur J Pharmacol; 1978 Dec; 52(3-4):271-80. PubMed ID: 729639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOME OBSERVATIONS ON THE PHARMACOLOGY OF ALPHA-METHYLDOPA.
    DAY MD; RAND MJ
    Br J Pharmacol Chemother; 1964 Feb; 22(1):72-86. PubMed ID: 14126060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the hypotensive action of alpha-methyldopamine.
    Finch L; Hersom A; Hicks P
    Br J Pharmacol; 1975 Aug; 54(4):445-51. PubMed ID: 1100157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adrenaline depletion in the hypothalamus of the rat after chronic alpha-methyldopa.
    Beart PM; Prosser D; Louis WJ
    Clin Exp Pharmacol Physiol; 1981 Jan; 8(1):25-31. PubMed ID: 7471519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that the hypotensive action of methyldopa is mediated by central actions of methylnoradrenaline.
    Henning M; Rubenson A
    J Pharm Pharmacol; 1971 Jun; 23(6):407-11. PubMed ID: 4397178
    [No Abstract]   [Full Text] [Related]  

  • 8. Centrally induced hypotension by alpha-methyldopa and alpha-methylnoradrenaline in normotensive and renal hypertensive rats.
    Nijkamp FP; De Jong W
    Prog Brain Res; 1977; 47():349-68. PubMed ID: 337354
    [No Abstract]   [Full Text] [Related]  

  • 9. Antihypertensive metabolites of alpha-methyldopa.
    Robertson D; Tung CS; Goldberg MR; Hollister AS; Gerkens JF; Oates JA
    Hypertension; 1984; 6(5 Pt 2):II45-50. PubMed ID: 6094349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of DOPA decarboxylase inhibitors with the effect of alpha-methyldopa on blood pressure and tissue monoamines in rats.
    Henning M
    Acta Pharmacol Toxicol (Copenh); 1969; 27(2):135-48. PubMed ID: 5819569
    [No Abstract]   [Full Text] [Related]  

  • 11. Liberation of alpha-methyldopamine as a "false" sympathetic transmitter after pretreatment of cats with alpha-methyldopa and disulfiram.
    Thoenen H; Haefely W; Gey KF; Hürlmann A
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 258(2):181-96. PubMed ID: 4385111
    [No Abstract]   [Full Text] [Related]  

  • 12. Correlation between fall in blood pressure and in vivo amine release after alpha-methylDOPA.
    Kapoor V; Chalmers J
    Eur J Pharmacol; 1989 May; 164(3):531-8. PubMed ID: 2767124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism of carbidopa to alpha-methyldopamine and alpha-methylnorepinephrine in rats.
    Shelton RC; Karoum F; Chuang LW; Wyatt RJ
    Biochem Pharmacol; 1985 Oct; 34(20):3623-6. PubMed ID: 3902027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of methyldopa metabolites on amine transmitters and adrenergic receptors in rat brain.
    Louis WJ; Conway E; Summers R; Beart P; Jarrott B
    Hypertension; 1984; 6(5 Pt 2):II40-4. PubMed ID: 6094348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. alpha-Methyldopa, alpha-methyldopamine an alpha-methylnoradrenaline: substrates for the thermolabile form of human platelet phenol sulphotransferase.
    Mwaluko G; Weinshilboum R
    Br J Clin Pharmacol; 1982 Aug; 14(2):231-9. PubMed ID: 7049213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of alpha-methyl dopa on the reserpine-induced suppression of motor activity and the conditioned avoidance response.
    Uretsky NJ; Seiden LS
    J Pharmacol Exp Ther; 1969 Jul; 168(1):153-62. PubMed ID: 4307318
    [No Abstract]   [Full Text] [Related]  

  • 17. Chlorpromazine interactions with guanethidine and alpha-methyldopa: effects on arterial pressure control and heart rate in renovascular hypertensive rats.
    Rankin GO; Watkins BE; Sawutz DG
    Arch Int Pharmacodyn Ther; 1982 Nov; 260(1):130-40. PubMed ID: 7165417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homologs of dopa, alpha-methyldopa, and dopamine as potential cardiovascular drugs.
    Winn M; Rasmussen R; Minard F; Kyncl J; Plotnikoff N
    J Med Chem; 1975 Apr; 18(4):434-7. PubMed ID: 1079053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of alpha-methylnoradrenaline and alpha-methyldopamine in reserpine-induced ulcers in rats.
    Sandor V; Cuparencu B
    Pharmacology; 1981; 23(2):91-4. PubMed ID: 7031706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in brain alpha-adrenergic receptors after alpha-methyldopa administration to spontaneously hypertensive rats.
    Freed CR; Wang CH; U'Prichard DC
    Hypertension; 1984; 6(5 Pt 2):II34-9. PubMed ID: 6094347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.